Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Titanium-Reinforced PTFE Membranes for Bone Augmentation

NCT: NCT07520903 · COMPLETED

NCT IDNCT07520903
StatusCOMPLETED
Start Date2022-04-01
Completion2024-06-01

Brief Summary

This prospective comparative clinical study evaluated vertical and horizontal bone gain after guided bone regeneration using titanium-reinforced dense PTFE (TiR-dPTFE) membranes versus reinforced PTFE mesh (RPM) in patients requiring ridge augmentation prior to implant placement. Radiographic outcomes were assessed using CBCT at baseline, 9 months, and 12 months. Histological evaluation was performed in selected cases. Healing events and complications were recorded.

Frequently Asked Questions

What is Titanium-Reinforced PTFE Membranes for Bone Augmentation?

Titanium-Reinforced PTFE Membranes for Bone Augmentation is a clinical trial registered under NCT07520903. Current status: COMPLETED.

What is the status of NCT07520903?

The current status of NCT07520903 (Titanium-Reinforced PTFE Membranes for Bone Augmentation) is: COMPLETED.

When did Titanium-Reinforced PTFE Membranes for Bone Augmentation start?

Titanium-Reinforced PTFE Membranes for Bone Augmentation started on 2022-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑